Because of their stability and low diurnal variation compared to GH, IGF-1 and IGFBP-3 levels are used to screen for GH secretory disorders, including gigantism, acromegaly, and GH deficiency, and to monitor GH treatment for short stature [11]. Here, IGF1 is linked to acromegaly.